Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Patents • Litigation • Annual Sales • Drug Prices • Drugs in Development

Make Better Decisions

  Start Trial

NEW Daily email alerts on drug approvals, patents, litigation, and more…

See Plans and Pricing

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Track 505(b)(2) entrants

Monitor 505(b)(2) activity

  • Anticipate 505(b)(2) approvals
  • Track OTC-switches, new formulations, and other drug improvements
  • Strengthen new formulation patents by studying prior claims and litigation
Drug Prices

Find and Evaluate Business Opportunities

  • Assess levels of generic competition
  • Use drug price ranges to evaluate price elasticity
  • Determine optimal prices before launch
Drug Patent Litigation

Get Confidential Royalty and Settlement Terms

  • Study failed patent challenges to develop a better strategy
  • Collect competitive intelligence by examining contractual disputes
  • Track litigation to anticipate early generic entry
Drug Sales Histories and Profiles

Refine Your Market-Entry Strategy

  • Assess market potential through historic sales figures
  • Evaluate buyer power with data on reimbursement segmentation
  • Align distribution methods with information on where and how drugs are purchased
Drug Profile

Global Biopharmaceutical Business Intelligence

  • Identify and evaluate commercial opportunities
  • Branded and generic drug pipeline forecasting
  • Anticipate future revenue events
  • Identify API and finished drug product suppliers
Global Drug Patents in 134 Countries

Global Drug Patents

  • Drug Patents in 134 Countries
  • Evaluate branded and generic market opportunities globally
Drug synonyms

Prior art search support

  • Exhaustive list of synonyms to aid in your patent searches
  • Clinical trial histories to support patent challenges
  • Find prior art in expired patents
  • Search for claims across all patents
Find Generic Drug Entry Opportunities

Find Generic Drug Entry Opportunities

  • Inform portfolio management decisions
  • Sector landscaping and due diligence
  • Track drugs in development and explore new indications for existing drugs

Clients in 67 Countries

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson